Loading data
SCCONYSE
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 13.42 bn USD | 11.43 bn USD | 9.9 bn USD | 10.05 bn USD | 10.93 bn USD |
| Cost of revenue | 5.36 bn USD | 4.84 bn USD | 4.69 bn USD | 4.65 bn USD | 3.89 bn USD |
| Selling, general and administrative expense | 137.8 m USD | 130.5 m USD | 127.2 m USD | 125 m USD | 125.2 m USD |
| Operating profit | 7 bn USD | 5.55 bn USD | 4.19 bn USD | 4.44 bn USD | 6.07 bn USD |
| Income tax expense | 2.47 bn USD | 1.98 bn USD | 1.52 bn USD | 1.6 bn USD | 2.3 bn USD |
| Net income (reported basis) | 4.33 bn USD | 3.38 bn USD | 2.43 bn USD | 2.64 bn USD | 3.4 bn USD |
| Net income attributable to common shareholders | 4.33 bn USD | 3.38 bn USD | 2.43 bn USD | 2.64 bn USD | 3.4 bn USD |
| Basic earnings per share | 5.24 USD/share | 4.21 USD/share | 3.05 USD/share | 3.41 USD/share | 4.39 USD/share |
| Diluted earnings per share | 5.24 USD/share | 4.21 USD/share | 3.05 USD/share | 3.41 USD/share | 4.39 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.